NO20045547L - Preparater og fremgangsmate for behandling av infeksjon i storfe og gris - Google Patents

Preparater og fremgangsmate for behandling av infeksjon i storfe og gris

Info

Publication number
NO20045547L
NO20045547L NO20045547A NO20045547A NO20045547L NO 20045547 L NO20045547 L NO 20045547L NO 20045547 A NO20045547 A NO 20045547A NO 20045547 A NO20045547 A NO 20045547A NO 20045547 L NO20045547 L NO 20045547L
Authority
NO
Norway
Prior art keywords
cattle
pigs
methods
preparations
treating infection
Prior art date
Application number
NO20045547A
Other languages
English (en)
Norwegian (no)
Inventor
Abu S Huq
Kanwal J Varma
Raul E Kohan
Robert D Simmons
Keith A Freehauf
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of NO20045547L publication Critical patent/NO20045547L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20045547A 2002-05-20 2004-12-17 Preparater og fremgangsmate for behandling av infeksjon i storfe og gris NO20045547L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38201502P 2002-05-20 2002-05-20
PCT/IB2003/002152 WO2003097054A1 (en) 2002-05-20 2003-05-19 Compositions and method for treating infection in cattle and swine

Publications (1)

Publication Number Publication Date
NO20045547L true NO20045547L (no) 2004-12-17

Family

ID=29550174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045547A NO20045547L (no) 2002-05-20 2004-12-17 Preparater og fremgangsmate for behandling av infeksjon i storfe og gris

Country Status (28)

Country Link
US (3) US6790867B2 (es)
EP (1) EP1505975B1 (es)
JP (2) JP4772324B2 (es)
KR (1) KR101102176B1 (es)
CN (1) CN100563655C (es)
AR (1) AR039826A1 (es)
AU (1) AU2003228042B2 (es)
BR (1) BRPI0311126B1 (es)
CA (1) CA2485491C (es)
CY (1) CY1107176T1 (es)
DE (1) DE60317662T2 (es)
DK (1) DK1505975T3 (es)
EC (1) ECSP045442A (es)
ES (1) ES2295583T3 (es)
IL (2) IL165252A0 (es)
MX (1) MXPA04011516A (es)
MY (1) MY135791A (es)
NO (1) NO20045547L (es)
NZ (1) NZ536476A (es)
PE (1) PE20040041A1 (es)
PL (1) PL213975B1 (es)
PT (1) PT1505975E (es)
RU (2) RU2330662C2 (es)
SI (1) SI1505975T1 (es)
TW (1) TWI355266B (es)
UA (1) UA81629C2 (es)
WO (1) WO2003097054A1 (es)
ZA (1) ZA200409296B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US6432203B1 (en) * 1997-03-17 2002-08-13 Applied Komatsu Technology, Inc. Heated and cooled vacuum chamber shield
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
BRPI0213425B8 (pt) * 2001-10-19 2021-05-25 Idexx Lab Inc composições injetáveis para a liberação controlada de composto farmacologicamente ativo, usos do referido composto e método para suas preparações
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
PE20050386A1 (es) * 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050148519A1 (en) * 2003-10-29 2005-07-07 Murthy Yerramilli V.S. Salts of pharmacologically active compounds
KR100548948B1 (ko) * 2003-11-24 2006-02-02 주식회사 한동 플로르페니콜의 약제학적 조성물
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
WO2007058639A2 (en) * 2004-09-02 2007-05-24 Idexx Laboratories Inc. Antibacterial agents
DK1830885T3 (da) * 2004-12-21 2009-01-05 Intervet Int Bv Injicerbar veterinærmedicinsk sammensætning omfattende florfenicol
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US7518017B2 (en) 2006-02-17 2009-04-14 Idexx Laboratories Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
EP2091909A1 (en) * 2006-12-13 2009-08-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
CN101600686A (zh) * 2006-12-13 2009-12-09 先灵-普劳有限公司 氯霉素、甲砜霉素及其类似物的水溶性前药
RU2009127496A (ru) * 2006-12-19 2011-01-27 Шеринг-Плоу Лтд. (CH) Шипучие препараты флорфеникола для добавления в системы питьевой воды
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
RU2342656C2 (ru) * 2007-01-09 2008-12-27 Государственное образовательное учреждение высшего профессионального образования "Оренбургская медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ОрГМА Росздрава) Способ прогнозирования осложненного течения флегмон
US20090062397A1 (en) * 2007-04-27 2009-03-05 Schering-Plough Animal Health Corporation Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
US7550625B2 (en) 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
CN101917973B (zh) * 2007-12-14 2013-10-09 英特威国际有限公司 从药物组合物中回收氟尼辛的方法
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2009143558A1 (en) * 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
CN101461821B (zh) * 2008-07-04 2011-05-18 青岛康地恩药业有限公司 一种用于治疗猪、牛呼吸道疾病的复方口服药物组合物
MX2011000859A (es) 2008-07-23 2011-02-24 Ambrx Inc Polipeptidos g-csf bovinos modificados y sus usos.
JP2011529895A (ja) * 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
BRPI1002021A2 (pt) * 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
CN102188422B (zh) * 2011-01-11 2013-11-06 广东大华农动物保健品股份有限公司 一种复方氟苯尼考注射液及其制备方法和应用
EA019956B1 (ru) * 2011-02-24 2014-07-30 Закрытое Акционерное Общество "Нита-Фарм" Фармацевтическая композиция для лечения заболеваний бактериальной и микоплазменной этиологии
UA110436C2 (en) * 2012-03-06 2015-12-25 Zoetis Llc Antibacterial phenol compounds
WO2014051939A1 (en) * 2012-09-26 2014-04-03 Zoetis Llc Phenicol antibacterial agents
CN102920701A (zh) * 2012-11-02 2013-02-13 青岛康地恩药业股份有限公司 一种用于治疗猪呼吸道感染疾病的复方氟苯尼考制剂及其制备方法
CN104208062A (zh) * 2013-06-03 2014-12-17 中国农业科学院兰州畜牧与兽药研究所 一种高浓度复方氟苯尼考注射液及其制备方法和应用
CN104095996A (zh) * 2014-08-12 2014-10-15 王忠亮 一种治疗急性脓肿期乳腺炎的药物组合物
CN104188901A (zh) * 2014-08-12 2014-12-10 河南迪冉生物科技有限公司 一种兽用氟苯尼考注射液及其制备方法
CN104370782A (zh) * 2014-11-29 2015-02-25 郑州后羿制药有限公司 一种氟苯尼考的精制方法
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
USD1126398S1 (en) 2018-06-15 2026-05-12 James T. Doubet Syringe adapter for medication
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
CN108904442B (zh) * 2018-08-09 2021-04-06 山西瑞象生物药业有限公司 一种氟苯尼考溶液剂及其制备方法
MX2021002492A (es) * 2018-09-06 2021-09-08 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Formulación antibiótica inyectable de liberación sostenida.
CN110208397B (zh) * 2019-05-17 2022-08-19 河北远征药业有限公司 一种同时测定土霉素氟尼辛注射液中两种主药含量的高效液相色谱法
EP4251205A1 (en) * 2020-11-25 2023-10-04 Intervet International B.V. Method of treatment of pain through buccal administration of flunixin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025325A1 (de) * 1980-07-04 1982-02-04 Merck Patent Gmbh, 6100 Darmstadt Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
ES2163147T3 (es) 1997-05-06 2002-01-16 Norbrook Lab Ltd Perfeccionamientos de agentes antimicrobianos de accion prolongada o relativos a los mismos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての8a−アザライド
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
KR20020024587A (ko) * 1999-05-14 2002-03-30 린다 에스. 스티븐슨 염증 매개성 감염에 대한 항염증 치료
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US6790867B2 (en) 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
PE20050386A1 (es) 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol

Also Published As

Publication number Publication date
CN1652783A (zh) 2005-08-10
BRPI0311126B1 (pt) 2016-11-08
CA2485491A1 (en) 2003-11-27
TW200307536A (en) 2003-12-16
MXPA04011516A (es) 2005-02-14
ZA200409296B (en) 2005-07-27
TWI355266B (en) 2012-01-01
DE60317662T2 (de) 2008-10-30
AU2003228042B2 (en) 2006-09-21
CA2485491C (en) 2012-12-04
SI1505975T1 (sl) 2008-06-30
CN100563655C (zh) 2009-12-02
US20030216447A1 (en) 2003-11-20
WO2003097054A1 (en) 2003-11-27
US20030220302A1 (en) 2003-11-27
ES2295583T3 (es) 2008-04-16
BR0311126A (pt) 2005-03-08
JP2006213731A (ja) 2006-08-17
KR101102176B1 (ko) 2012-01-02
RU2466726C2 (ru) 2012-11-20
RU2008107582A (ru) 2009-09-10
AR039826A1 (es) 2005-03-02
DK1505975T3 (da) 2008-01-14
EP1505975B1 (en) 2007-11-21
IL165252A (en) 2011-11-30
KR20050010818A (ko) 2005-01-28
EP1505975A1 (en) 2005-02-16
RU2004137273A (ru) 2005-07-10
RU2330662C2 (ru) 2008-08-10
DE60317662D1 (de) 2008-01-03
US6790867B2 (en) 2004-09-14
AU2003228042A1 (en) 2003-12-02
IL165252A0 (en) 2005-12-18
PE20040041A1 (es) 2004-01-24
MY135791A (en) 2008-06-30
JP4772324B2 (ja) 2011-09-14
PT1505975E (pt) 2008-01-31
UA81629C2 (ru) 2008-01-25
US8044102B2 (en) 2011-10-25
PL213975B1 (pl) 2013-05-31
PL374575A1 (en) 2005-10-31
ECSP045442A (es) 2005-01-03
NZ536476A (en) 2008-10-31
US20050288261A1 (en) 2005-12-29
JP2005526849A (ja) 2005-09-08
CY1107176T1 (el) 2012-10-24
HK1072547A1 (en) 2005-09-02

Similar Documents

Publication Publication Date Title
MY135791A (en) Compositions and method for treating infection in cattle and swine
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
NO20055216L (no) Nye hydroksamater som terapeutiske midler
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
NO20050497L (no) Anvendelse av CETP inhibitorer og eventuelt HMG COA reduserbare inhibitorer og/eller antihypertensiva
TW200833367A (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
PA8603201A1 (es) Procedimiento y composiciones farmaceuticas para el tratamiento de arterosclerosis, dislipidemias y afecciones relacionadas
DK1280799T3 (da) Orthosubstituerede anthranilsyreamider og anvendelse heraf som lægemidler
NO20004282L (no) Matriksproteinpreparater for sÕrheling
NO20055144L (no) Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
BR0312584A (pt) Novas substâncias anti-inflamatórias não-esteróides, compostos e métodos para o uso das mesmas
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
BRPI0410490A (pt) composto de macrolìdeo, composição farmacêutica e método de tratamento compreendendo o mesmo
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
NO20050718L (no) Topikal behandling av hudsykdommer
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
WO2004010934A3 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application